Stay updated on MND-2119 Long-Term Safety/Efficacy in Hypertriglyceridemia Clinical Trial
Sign up to get notified when there's something new on the MND-2119 Long-Term Safety/Efficacy in Hypertriglyceridemia Clinical Trial page.

Latest updates to the MND-2119 Long-Term Safety/Efficacy in Hypertriglyceridemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3. This update does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.0 to v3.4.2 in the page footer, indicating a minor site update; this does not affect study content or how a user interacts with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded a glossary toggle and updated study metadata, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label to v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed and replaced.SummaryDifference0.3%

- Check82 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedFooter/navigation updates: added a new Revision: v3.3.3 and removed the HHS Vulnerability Disclosure link along with Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to MND-2119 Long-Term Safety/Efficacy in Hypertriglyceridemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MND-2119 Long-Term Safety/Efficacy in Hypertriglyceridemia Clinical Trial page.